17-03-2025 08:00 via wallstreet-online.de

Hemogenyx Pharmaceuticals PLC Announces Recruitment of Second Patient for Clinical Trials

Recruitment of Second Patient for HG-CT-1 Clinical Trial LONDON, GB / ACCESS Newswire / March 17, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce the recruitment of the second patient for its clinical trial of HG-CT-1, its …
Jetzt den vollständigen Artikel lesen
Weiterlesen »